M&A Deal Summary

Fagron Acquires Letco Med

On February 2, 2022, Fagron acquired medical products company Letco Med from The Harvard Drug Group for 34M USD

Acquisition Highlights
  • This is Fagron’s 9th transaction in the Medical Products sector.
  • This is Fagron’s 2nd largest (disclosed) transaction.
  • This is Fagron’s 4th transaction in the United States.
  • This is Fagron’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2022-02-02
Target Letco Med
Sector Medical Products
Buyer(s) Fagron
Sellers(s) The Harvard Drug Group
Deal Type Divestiture
Deal Value 34M USD

Target

Letco Med

Wayne, Pennsylvania, United States
Letco Med provides turnkey solutions for pharmacies worldwide, specializing in respiratory and compounded, customized medications, as well as technology-driven diagnostics. Letco Med offers a suite of pharmacy operations consulting, compounding chemicals, equipment and supplies, pre-mix medications, and industrial facilities equipment. Letco Med is based in Wayne, Pennsylvania.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Fagron

Nazareth, Belgium
Category Company
Founded 1990
Sector Medical Products
Employees3,282
Revenue 762M EUR (2023)
DESCRIPTION

Fagron is a provider of pharmaceutical raw materials, compounded products, repacked goods, packaging materials and pharmacy equipment. Fagron was founded in 1990 and is based in Nazareth, Belgium.

DEAL STATS #
Overall 11 of 11
Sector (Medical Products) 9 of 9
Type (Divestiture) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 4 of 4
Year (2022) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-13 CEDROSA

Naucalpan de Juárez, Mexico

Central de Drogas, S.A. de C.V. is a supplier of raw materials (essentials) to compounding pharmacies and the pharmaceutical industry. The company was formed in 1944 and is based in Naucalpan, Mexico.

Buy $463M

Seller(S) 1

SELLER

The Harvard Drug Group

Livonia, Michigan, United States
Category Company
Sector Distribution
DESCRIPTION

The Harvard Drug Group LLC is a pharmaceutical distributor in the United States. Harvard Drug supplies generic and branded pharmaceuticals to over 6,000 retail customers, which include independent, regional and national pharmacies.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-29 The Rugby Group

California, United States

Rugby OTC consists of more than 250 SKUs of cough and cold, allergy, pain relief, nausea relief, nicotine gum, vitamin and nutritional supplement products which are sold through various healthcare outlets across the United States.

Buy $117M
Mergr

Product

Company

Legal